S'abonner

Second trimester short cervix is associated with decreased abundance of cervicovaginal lipid metabolites - 20/07/22

Doi : 10.1016/j.ajog.2022.04.031 
Kristin D. Gerson, MD, PhD a, b, , Nancy Yang, BA a, Lauren Anton, PhD a, Maayan Levy, PhD b, Jacques Ravel, PhD c, Michal A. Elovitz, MD a, b, Heather H. Burris, MD, MPH a, d
a Center for Research on Reproduction and Women’s Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 
b Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 
c Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 
d Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 

Corresponding author: Kristin D. Gerson, MD, PhD.

Abstract

Background

A short cervix is a risk factor for preterm birth. The molecular drivers of a short cervix remain elusive. Metabolites may function as mediators of pathologic processes.

Objective

We sought to determine if a distinct cervicovaginal metabolomic profile is associated with a short cervix (<25 mm) to unveil the potential mechanisms by which premature cervical remodeling leads to a short cervix.

Study Design

This was a secondary analysis of a completed prospective pregnancy cohort. Cervicovaginal fluid was obtained between 20 and 24 weeks’ gestation. The participants selected for metabolomic profiling were frequency-matched by birth outcome and cervicovaginal microbiota profile. This analysis included 222 participants with cervical length measured. A short cervix was defined as one having length <25 mm, as measured by transvaginal ultrasound. Unpaired t-tests were performed with a Bonferroni correction for multiple comparisons.

Results

There were 27 participants with a short cervix, and 195 with normal cervical length. Of the 637 metabolites detected, 26 differed between those with a short cervix and those with normal cervical lengths; 22 were decreased, of which 21 belonged to the lipid metabolism pathway (all P<.000079). Diethanolamine, erythritol, progesterone, and mannitol or sorbitol were increased in the cases of short cervix. Among participants with Lactobacillus-deficient microbiota, only diethanolamine and mannitol or sorbitol differed between short cervix (n=17) and normal cervical length (n=75), both increased.

Conclusion

A short cervix is associated with decreased cervicovaginal lipid metabolites, particularly sphingolipids. This class of lipids stabilizes cell membranes and protects against environmental exposures. Increased diethanolamine—an immunostimulatory xenobiotic—is associated with a short cervix. These observations begin to identify the potential mechanisms by which modifiable environmental factors may invoke cell damage in the setting of biological vulnerability, thus promoting premature cervical remodeling in spontaneous preterm birth.

Le texte complet de cet article est disponible en PDF.

Key words : metabolites, metabolome, microbiome, short cervix, spontaneous preterm birth


Plan


 M.A.E. receives salary support from the National Institutes of Health (NIH; The National Institute of Nursing Research, National Institute of Allergy and Infectious Disease, and Eunice Kennedy Shriver National Institute of Child Health and Human Development). She is also a consultant for Mirvie. The other authors report no conflict of interest.
 Society for Maternal-Fetal Medicine/American Association of Obstetricians and Gynecologists Foundation Award (K.G.); NIH R01NR014784 (M.A.E.). The funding sources had no role in study design; collection, analysis, and interpretation of data; writing of the report; or in the decision to submit the article for publication.
 This work was accepted as an oral abstract (#9) in the 42nd annual meeting of the Society for Maternal-Fetal Medicine, Orlando, FL, January 31–February 5, 2022.
 Cite this article as: Gerson KD, Yang N, Anton L, et al. Second trimester short cervix is associated with decreased abundance of cervicovaginal lipid metabolites. Am J Obstet Gynecol 2022;227:273.e1-18.


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 227 - N° 2

P. 273.e1-273.e18 - août 2022 Retour au numéro
Article précédent Article précédent
  • Arabin pessary to prevent adverse perinatal outcomes in twin pregnancies with a short cervix: a multicenter randomized controlled trial (PESSARONE)
  • Marion Groussolles, Norbert Winer, Loïc Sentilhes, Florence Biquart, Mona Massoud, Alexandre J. Vivanti, Hanane Bouchghoul, Patrick Rozenberg, Pascale Olivier, Raoul Desbriere, Celine Chauleur, Franck Perrotin, Frederic Coatleven, Florent Fuchs, Florence Bretelle, Vassilis Tsatsaris, Laurent J. Salomon, Nicolas Sananes, Gilles Kayem, Veronique Houflin-Debarge, Thomas Schmitz, Guillaume Benoist, Catherine Arnaud, Virginie Ehlinger, Christophe Vayssière, Groupe de Recherche en Gynecologie Obstétrique
| Article suivant Article suivant
  • In vivo Raman spectroscopy monitors cervical change during labor
  • Laura E. Masson, Christine M. O’Brien, Rekha Gautam, Giju Thomas, James C. Slaughter, Mack Goldberg, Kelly Bennett, Jennifer Herington, Jeff Reese, Emad Elsamadicy, J. Michael Newton, Anita Mahadevan-Jansen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.